These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36889298)

  • 1. Interleukin-33 Ameliorates Murine Systemic Lupus Erythematosus and Is Associated with Induction of M2 Macrophage Polarisation and Regulatory T Cells.
    Mok MY; Law KS; Kong WY; Luo CY; Asfaw ET; Chan KW; Huang FP; Lau CS; Chan GCF
    J Innate Immun; 2023; 15(1):485-498. PubMed ID: 36889298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice.
    Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS
    Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-2/anti-IL-2 complexes ameliorate lupus nephritis by expansion of CD4
    Yan JJ; Lee JG; Jang JY; Koo TY; Ahn C; Yang J
    Kidney Int; 2017 Mar; 91(3):603-615. PubMed ID: 27914701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-33 Orchestrated the Interaction and Immunoregulatory Functions of Alternatively Activated Macrophages and Regulatory T Cells In Vitro.
    Mok MY; Luo CY; Huang FP; Kong WY; Chan GCF
    J Immunol; 2023 Oct; 211(7):1134-1143. PubMed ID: 37566486
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic effects of artesunate on lupus-prone MRL/lpr mice are dependent on T follicular helper cell differentiation and activation of JAK2-STAT3 signaling pathway.
    Dang WZ; Li H; Jiang B; Nandakumar KS; Liu KF; Liu LX; Yu XC; Tan HJ; Zhou C
    Phytomedicine; 2019 Sep; 62():152965. PubMed ID: 31129432
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early Treatment of Interleukin-33 can Attenuate Lupus Development in Young NZB/W F1 Mice.
    Mohd Jaya FN; Liu Z; Chan GC
    Cells; 2020 Nov; 9(11):. PubMed ID: 33182616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-9 Is Associated with Elevated Anti-Double-Stranded DNA Antibodies in Lupus-Prone Mice.
    Yang J; Li Q; Yang X; Li M
    Mol Med; 2015 Apr; 21(1):364-70. PubMed ID: 25902303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-6 promotes systemic lupus erythematosus progression with Treg suppression approach in a murine systemic lupus erythematosus model.
    Mao X; Wu Y; Diao H; Hao J; Tian G; Jia Z; Li Z; Xiong S; Wu Z; Wang P; Zhao L; Yin Z
    Clin Rheumatol; 2014 Nov; 33(11):1585-93. PubMed ID: 24928344
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paeoniflorin ameliorates murine lupus nephritis by increasing CD4
    Liang CL; Lu W; Qiu F; Li D; Liu H; Zheng F; Zhang Q; Chen Y; Lu C; Li B; Dai Z
    Biochem Pharmacol; 2021 Mar; 185():114434. PubMed ID: 33513343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-33 neutralization suppresses lupus disease in lupus-prone mice.
    Li P; Lin W; Zheng X
    Inflammation; 2014 Jun; 37(3):824-32. PubMed ID: 24398614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin 6 (IL-6) deficiency delays lupus nephritis in MRL-Faslpr mice: the IL-6 pathway as a new therapeutic target in treatment of autoimmune kidney disease in systemic lupus erythematosus.
    Cash H; Relle M; Menke J; Brochhausen C; Jones SA; Topley N; Galle PR; Schwarting A
    J Rheumatol; 2010 Jan; 37(1):60-70. PubMed ID: 19955044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4(+)B220(+)TCRγδ(+) T cells produce IL-17 in lupus-prone MRL/lpr mice.
    Qiu F; Li T; Zhang K; Wan J; Qi X
    Int Immunopharmacol; 2016 Sep; 38():31-9. PubMed ID: 27235595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glomerular cytokine expression in murine lupus nephritis.
    Tshilela KA; Ikeuchi H; Matsumoto T; Kuroiwa T; Sakurai N; Sakairi T; Kaneko Y; Maeshima A; Hiromura K; Nojima Y
    Clin Exp Nephrol; 2016 Feb; 20(1):23-9. PubMed ID: 25985839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Y27, a novel derivative of 4-hydroxyquinoline-3-formamide, prevents the development of murine systemic lupus erythematosus-like diseases in MRL/lpr autoimmune mice and BDF1 hybrid mice.
    Xiao ZY; Chen SH; Cheng JP; Zhou WX; Zhang YX; Yang RF; Yun LH
    Arthritis Res Ther; 2012 Nov; 14(6):R235. PubMed ID: 23116248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-25 is upregulated in patients with systemic lupus erythematosus and ameliorates murine lupus by inhibiting inflammatory cytokine production.
    Li Y; Wang R; Liu S; Liu J; Pan W; Li F; Li J; Meng D
    Int Immunopharmacol; 2019 Sep; 74():105680. PubMed ID: 31200339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nasal anti-CD3 antibody ameliorates lupus by inducing an IL-10-secreting CD4+ CD25- LAP+ regulatory T cell and is associated with down-regulation of IL-17+ CD4+ ICOS+ CXCR5+ follicular helper T cells.
    Wu HY; Quintana FJ; Weiner HL
    J Immunol; 2008 Nov; 181(9):6038-50. PubMed ID: 18941193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of microRNA-448 suppresses CD4
    Zhang J; Guo Y; Sun Y; Chang L; Wang X
    Biochem Biophys Res Commun; 2022 Mar; 596():88-96. PubMed ID: 35121374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Piperlongumine alleviates lupus nephritis in MRL-Fas(lpr) mice by regulating the frequency of Th17 and regulatory T cells.
    Yao L; Chen HP; Ma Q
    Immunol Lett; 2014 Sep; 161(1):76-80. PubMed ID: 24837470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased CD45RA+ FoxP3(low) regulatory T cells with impaired suppressive function in patients with systemic lupus erythematosus.
    Pan X; Yuan X; Zheng Y; Wang W; Shan J; Lin F; Jiang G; Yang YH; Wang D; Xu D; Shen L
    PLoS One; 2012; 7(4):e34662. PubMed ID: 22506043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte colony-stimulating factor treatment ameliorates lupus nephritis through the expansion of regulatory T cells.
    Yan JJ; Jambaldorj E; Lee JG; Jang JY; Shim JM; Han M; Koo TY; Ahn C; Yang J
    BMC Nephrol; 2016 Nov; 17(1):175. PubMed ID: 27846813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.